Product Information
VENLAFAXINE HCL ER 37.5 MG TAB is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.4938 per EA under NDC 70710134803. Its NADAC has been published 184 times since Dec 21, 2022.
Strength
37.5 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710134803
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215622On Market Since
9/1/2022
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 37.5 MG TAB has been published 184 times since Dec 21, 2022, and over the history we have for it it has declined 75.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4938 per EA |
|---|---|
| All-time high | $2.0495 (Mar 15, 2023) |
| All-time low | $0.3039 (Jan 22, 2025) |
| 52-week high | $0.6661 |
| 52-week low | $0.3302 |
| Median price | $0.5397 |
| Average price | $0.7299 |
| Largest weekly change | -56.8% (Apr 17, 2024) |
| Weeks tracked | 184 |
| Tracking since | Dec 21, 2022 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 84% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 37.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 37.5 MG TAB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.4938 per EA (NDC 70710134803), effective Jun 24, 2026.
How has the price of VENLAFAXINE HCL ER 37.5 MG TAB changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 37.5 MG TAB has declined 75.9%. It has been tracked across 184 weekly CMS publications since Dec 21, 2022.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 37.5 MG TAB?
Since Dec 21, 2022, the NADAC for VENLAFAXINE HCL ER 37.5 MG TAB has ranged from a low of $0.3039 (Jan 22, 2025) to a high of $2.0495 (Mar 15, 2023), with a median of $0.5397 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 37.5 MG TAB?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, VENLAFAXINE HCL 37.5 MG TABLET, is $0.0795 per EA — about 84% below VENLAFAXINE HCL ER 37.5 MG TAB.
Who manufactures VENLAFAXINE HCL ER 37.5 MG TAB?
VENLAFAXINE HCL ER 37.5 MG TAB (NDC 70710134803) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification